The 2017 American College of Cardiology/American Heart Association Guideline for the Management of Heart Failure [26] recommends measuring levels of cTn I, NT-proBNP and ST2/IL-33 when anticipating cardiac involvement and possible HF. This evidence concerns the gene TNNI3 and hydrops fetalis.